In November 2016, Dr. Migaud joined the University of South Alabama as a Professor of Oncologic Sciences at the Mitchell Cancer Institute. She previously served as Professor in Medicinal and Biological Chemistry for the School of Pharmacy at Queen’s University Belfast in Northern Ireland and a Levitt Visiting Professor in the department of Biochemistry at the Carver College of Medicine at the University of Iowa. Over the past decade, Dr. Migaud’s laboratory has developed an extensive chemical biology program that focuses on vitamin B3 and its role in health and disease. Her findings allow biologists to test specific NAD-dependent biological events that control cell survival, DNA repair and gene regulation. Her studies have opened the door to detailed analyses of a number of NAD metabolism processes and helped correlate how vitamin supplements impact health status and recovery following chemotherapy and radiotherapy treatment.
USA Health has a comprehensive biomedical research program that spans a wide range of clinical, basic and translational research. At the Mitchell Cancer Institute, our physicians and scientific investigators are searching for breakthrough discoveries to improve the lives of cancer patients.
The award is part of the NASA-funded institute’s Biomedical Research Advances for Space Health solicitation, which invests in emerging science with the potential to reduce risks to human health and performance during deep-space exploration.
Breakthrough technology is providing researchers at USA Health Mitchell Cancer Institute a more precise understanding of how cancer cells grow.
